v3.26.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities    
Net loss $ (5,861) $ (5,823)
Adjustments to reconcile net loss to cash used in operating activities:    
Depreciation 159 156
Amortization of intangibles 236 214
Loss on revaluation of contingent consideration 756 502
Non-cash lease expense (4)
Stock-based compensation 2,110 2,535
Changes in operating assets and liabilities:    
Accounts receivable 543 (500)
Inventories (928) (1,481)
Prepaid expenses and other current assets (599) 760
Other assets (52) 9
Accounts payable (49) 852
Accrued liabilities (587) 5
Deferred revenue 834 992
Net cash used in operating activities (3,442) (1,779)
Cash flows from investing activities    
Purchase of property and equipment (79)
Net cash used in investing activities (79)
Cash flows from financing activities    
Proceeds from issuance of stock 4,853 32
Equity issuance costs (137)
Net cash provided by financing activities 4,716 32
Net increase (decrease) in cash, cash equivalents, and restricted cash 1,195 (1,747)
Cash, cash equivalents, and restricted cash at beginning of period 13,421 12,436
Cash, cash equivalents, and restricted cash at end of period 14,616 10,689
Supplemental disclosure of cash flow information:    
Purchase of property and equipment included in accounts payable 17 23
Reconciliation of cash, cash equivalents, and restricted cash to consolidated balance sheet as of March 31st:    
Cash and cash equivalents 14,616 10,601
Restricted cash - current 88
Total cash, cash equivalents, and restricted cash $ 14,616 $ 10,689